Quanome Technologies, Inc. QNME
0.74
(0.07)
(8.64%)
as of 25 Sep
- Market cap
- $26.9M
- P/E
- 0.0×
Follow QNME
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.00 | 0.75 | 0.96 | 0.36 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
16.87 | (38.41) | (4.73) | (3.83) | |
P/B ratio |
1.77 | 1.43 | 2.73 | 2.26 | |
Price to Tangible BV |
1.81 | 1.48 | 2.91 | 2.59 | |
EV/Sales |
0.95 | 0.70 | 0.75 | 0.16 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.86) | (3.11) | (2.83) | (1.04) | |
EV/FCF |
(4.31) | (2.79) | (2.54) | (0.85) | |
Quick Ratio |
2.15 | 1.31 | 1.43 | 0.67 | |
Current Ratio |
4.27 | 2.03 | 1.52 | 1.06 | |
Net Debt/EBITDA |
0.43 | 3.85 | 3.63 | 3.98 | |
Debt/Assets |
0.75% | 1.62% | 2.50% | 8.06% | |
Debt/Equity |
0.01 | 0.03 | 0.07 | 0.41 | |
Asset Turnover |
1.74 | 1.36 | 1.35 | 1.51 | |
Operating CF/Net income |
10.03 | 0.29 | 2.96 | 1.88 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (1.53) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
181.48% | 44.41% | 37.66% | 34.25% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.03 | |
Share Based Compensation of Revenue |
86.51% | 8.30% | 5.89% | 0.00% | |
Graham Net Nets |
0.53 | 0.52 | 0.17 | (0.20) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(38.57%) | (47.19%) | (46.51%) | (81.18%) | |
Free Cash Flow Yield |
(22.07%) | (33.27%) | (30.89%) | (50.71%) | |
Revenue per Share |
0.04 | 0.36 | 0.41 | 1.27 | |
Operating CF per Share |
0.04 | (0.02) | (0.27) | (0.22) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.08) | |
Free Cash Flow per Share |
0.04 | (0.02) | (0.27) | (0.30) | |
Cash per Share |
0.04 | 0.08 | 0.31 | 0.64 | |
Shareholders Equity per Share |
0.40 | 0.62 | 0.47 | 0.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.40 | 0.62 | 0.47 | 0.38 | |
Free Cash Flow |
1.43 | (0.45) | (4.02) | (2.27) | |
Working Capital |
13.05 | 10.78 | 5.16 | 0.61 | |
Capital Expenditures |
— | — | — | (0.59) | |
Net Current Asset Value |
12.88 | 9.09 | 3.31 | (1.28) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.06 | |
Net Profit Margin |
10.73% | (22.58%) | (22.25%) | (9.29%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.53 | 6.98 | 5.97 | 2.46 | |
Average Payables |
1.31 | 2.20 | 1.74 | 1.20 | |
Average Inventory |
0.12 | 0.07 | — | — | |
Average Assets |
13.86 | 17.07 | 14.72 | 11.80 | |
Average Common Equity |
7.18 | 6.91 | 5.29 | 1.74 |
Columns are period end dates